Those who get allotment , do not worry , I have thoroughly research the company and the 30% gain to the price looks fairly valued , company is virtually debt free, has a complex portfolio of product , supriya life science was listed at 400 and went to near 600 , ipo price was 275 , supriya has least attractive as the product portfolio was least complex but the business was growing so it got value , and if Concord gives a 30% gain in quarterly result then there are also chance of 80 % gain , do not forget what people said about metro brands , mankind , rainbow medical care , manyavar, medanta , fusion microfinance, 5star business, even some of them are not fully subscribed in retail quota , If the company shows growth , then it is an organic one and investor find value in that
HDFC Bank: Rs 14820.00 debited from A/c XXXXXX8581 towards CONCORD BIOTECH LIMI on 11/08/23. Application No. 0e0635728e60ab, UMN: c7668b6f19ec42ybl. If not you, kindly report on